Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment

Thromb Res. 2015 Jul;136(1):180-1. doi: 10.1016/j.thromres.2015.05.006. Epub 2015 May 14.

Authors

Emilie P Belley-Côté¹, Richard P Whitlock¹, Benjamin French², Nathan Evaniew¹, Stephen E Kimmel³

Affiliations

¹ McMaster University, Hamilton, Ontario, Canada.
² University of Pennsylvania, Philadelphia, PA, Philadelphia, USA.
³ University of Pennsylvania, Philadelphia, PA, Philadelphia, USA. Electronic address: stevek@mail.med.upenn.edu.

PMID: 26004747
DOI: 10.1016/j.thromres.2015.05.006

No abstract available

Publication types

Letter
Comment

MeSH terms

Algorithms*
Female
Humans
Male
Pharmacogenetics / methods*
Thromboembolism / drug therapy*
Warfarin / pharmacology*

Substances

Warfarin